Explore Krystal Biotech, Inc.'s impressive financial turnaround with $290.5M revenue and $89.2M net income for 2024. A must-read for biotech investors!
Explore Axovant Gene Therapies Ltd's latest financial report, revealing revenue growth, rising net losses, and strategic recommendations for investors. Key insights on product sales and market position.
Explore Benitec Biopharma's Q4 2024 financial performance, key metrics, and strategic outlook amid ongoing losses and R&D investments.
Explore uniQure N.V.'s 8-K filing, detailing major events, share information, and legal identifiers crucial for investors as of January 7, 2025. Ticker: QURE.